We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$46.2B
AUM Growth
+$1.83B
Cap. Flow
-$543M
Cap. Flow %
-1.17%
Top 10 Hldgs %
24.86%
Holding
1,809
New
24
Increased
1,140
Reduced
325
Closed
37

Sector Composition

Rank Sector Weight
1 Technology 22.89%
2 Healthcare 18.49%
3 Financials 11.85%
4 Consumer Discretionary 9.1%
5 Industrials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDC icon
1051
Belden
BDC
$3.97B
$1.28M ﹤0.01%
14,749
+1,600
+12% +$133K
BCPC
1052
Balchem Corp
BCPC
$5.26B
$1.28M ﹤0.01%
10,114
+1,750
+21% +$226K
DB icon
1053
Deutsche Bank
DB
$67.9B
$1.28M ﹤0.01%
127,800
+23,500
+23% +$281K
FL
1054
DELISTED
Foot Locker
FL
$1.28M ﹤0.01%
32,160
CWT icon
1055
California Water Service
CWT
$3.1B
$1.28M ﹤0.01%
21,926
+1,950
+10% +$116K
CBRL icon
1056
Cracker Barrel
CBRL
$1.26B
$1.28M ﹤0.01%
11,231
+350
+3% +$38.3K
BEKE icon
1057
KE Holdings
BEKE
$17.7B
$1.27M ﹤0.01%
67,650
+20,150
+42% +$373K
NSIT icon
1058
Insight Enterprises
NSIT
$3.85B
$1.27M ﹤0.01%
8,895
+2,650
+42% +$330K
IDYA icon
1059
IDEAYA Biosciences
IDYA
$3.43B
$1.27M ﹤0.01%
92,411
HLI icon
1060
Houlihan Lokey
HLI
$9.72B
$1.27M ﹤0.01%
14,480
+2,670
+23% +$251K
THRX
1061
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$1.27M ﹤0.01%
142,598
BPMC
1062
DELISTED
Blueprint Medicines
BPMC
$1.27M ﹤0.01%
28,140
+1,600
+6% +$72.1K
GATX icon
1063
GATX Corp
GATX
$6.45B
$1.27M ﹤0.01%
11,499
+1,350
+13% +$147K
TMHC
1064
DELISTED
Taylor Morrison
TMHC
$1.26M ﹤0.01%
33,060
+2,450
+8% +$86.1K
SIG icon
1065
Signet Jewelers
SIG
$3.84B
$1.26M ﹤0.01%
16,200
+650
+4% +$48.2K
SPR
1066
DELISTED
Spirit AeroSystems
SPR
$1.26M ﹤0.01%
36,480
+600
+2% +$20.1K
TEX icon
1067
Terex
TEX
$7.37B
$1.26M ﹤0.01%
25,991
ALE
1068
DELISTED
Allete
ALE
$1.26M ﹤0.01%
19,526
CRSP icon
1069
CRISPR Therapeutics
CRSP
$4.69B
$1.25M ﹤0.01%
+27,700
New +$1.35M
FSS icon
1070
Federal Signal
FSS
$6.82B
$1.25M ﹤0.01%
23,106
+2,200
+11% +$115K
ABCL icon
1071
AbCellera Biologics
ABCL
$1.65B
$1.25M ﹤0.01%
166,000
UA icon
1072
Under Armour Class C
UA
$2.95B
$1.25M ﹤0.01%
146,280
+4,650
+3% +$42.8K
ONB icon
1073
Old National Bancorp
ONB
$10.2B
$1.25M ﹤0.01%
86,525
+7,635
+10% +$129K
PINC
1074
DELISTED
Premier
PINC
$1.24M ﹤0.01%
38,440
+7,250
+23% +$237K
SR icon
1075
Spire
SR
$4.79B
$1.24M ﹤0.01%
17,657

Similar funds

Ensign Peak Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Ensign Peak Advisors held 1,809 positions worth $46.2B, up 4.1% from $44.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 3.4%. Ensign Peak Advisors opened 24 new positions and exited 37, leaving the 1,809-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q1 2023 buy was State Street Financial Select Sector SPDR ETF: 1,117,296 shares worth $35.9M.
  • Ensign Peak Advisors added most to Eli Lilly in Q1 2023, an estimated $98M increase.
  • Ensign Peak Advisors's biggest Q1 2023 reduction was First Republic Bank, cutting an estimated $198M.
  • Ensign Peak Advisors fully exited iShares Russell 2000 ETF in Q1 2023, selling an estimated $179M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $46.2B portfolio in Q1 2023.
  • Ensign Peak Advisors opened 24 new positions and closed 37 in Q1 2023.
  • Ensign Peak Advisors's portfolio value rose 4.1% quarter-over-quarter to $46.2B.

Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.